Font Size




Menu Style

Larisa Gubareva, Centers for Disease Control and Prevention, USA

Larisa Gubareva

Dr Larisa Gubareva
Lead of the Molecular Epidemiology Team, Influenza Division, Centers for Disease Control and Prevention (CDC), Atlanta, USA

Dr Gubareva works in the CDC’s World Health Organization Collaborative Center for Surveillance, Epidemiology and Control of Influenza. Dr. Gubareva’s laboratory is responsible for monitoring drug resistance, developing new assays for virus characterization and training public health laboratories. Dr. Gubareva conducts research on broad aspects of influenza virology with emphasis on the molecular mechanisms of virus resistance to antiviral medications and risk assessment. Dr Gubareva is recognized internationally for her studies on influenza antivirals, drug resistance mechanisms, and new laboratory methods for influenza virus characterization.

Dr Gubareva is a member of the ISIRV Antiviral Group SIG and the WHO expert working group on surveillance of influenza antiviral susceptibility (AVWG) since its establishment in 2011. Over the years, she has participated in several international training courses on influenza virology and drug resistance monitoring. Dr. Gubareva is on Editorial Board of the Journal of Infectious Diseases, Influenza and Other Respiratory Viruses, Antimicrobial Agents and Chemotherapy. She also served on the board of the Antiviral Research for several years.